MEDINET announced that it had revised upward its consolidated net loss forecast for the fiscal year ending September 2026 to ¥1.42 billion. Full-year operating income is expected to show a wider loss while maintaining the previous forecast of a ¥1.45 billion loss, and the second-half plan was also revised.
On 16 October 2026, MEDINET disclosed a revision to its financial results forecast as a company listed on the TSE Growth market.
The consolidated net loss forecast for the fiscal year ending September 2026 was revised upward from the previous forecast of a ¥1.45 billion loss to a ¥1.42 billion loss, with the loss expected to narrow.
Meanwhile, the full-year operating loss forecast remained unchanged at ¥1.45 billion, with the loss expected to widen.
The second-half net loss forecast was also revised upward from the previous forecast of a ¥900 million loss to an ¥870 million loss.